お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、薬物および遺伝子送達システムの世界市場、容量、生産量、収益、価格の概要を紹介します。2020~2024年の歴史的な市場収益/売上データ、2025年の予想、および2031年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別に薬物および遺伝子送達システム市場を分類しています。
本レポートでは世界の薬物および遺伝子送達システム市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：Pfizer、Johnson & Johnson、Novartis、Roche、Merck & Co.、Sanofi、GlaxoSmithKline、AbbVie、AstraZeneca、Bayer、Bristol-MyersSquibb、Celgene、Amgen、Biogen、Gilead Sciences、Illumina、Regeneron Pharmaceuticals、Vertex Pharmaceuticals、Moderna、CRISPR Therapeutics

レポートは薬物および遺伝子送達システムの主要生産者を調査し、主要地域や国の消費状況も提供します。薬物および遺伝子送達システムの今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2020年から2031年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    Drug Delivery System
    Gene Delivery System

用途別の市場セグメント：
    Diabetes
    Central Nervous System
    Infectious Disease
    Oncology
    Other

本レポートの詳細内容
本レポートは、世界の薬物および遺伝子送達システム市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいて薬物および遺伝子送達システム市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2020年から2025年まで、そして2031年までの予測として、メーカー別、地域別（地域レベル、国レベル）の薬物および遺伝子送達システム生産量、成長率、市場シェアを調査している。

二. 消費面では、薬物および遺伝子送達システムの売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2020年から2025年まで、2031年までの予測。

三.主要メーカーの薬物および遺伝子送達システム売上高、収益、市場シェア、業界ランキング、2020年から2025年までのデータに焦点を当てています。世界の薬物および遺伝子送達システム市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本薬物および遺伝子送達システムのレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：薬物および遺伝子送達システムのレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2020～2031）
第2章： 薬物および遺伝子送達システムの世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2020～2031）
第3章：世界、地域、国レベルにおける薬物および遺伝子送達システムの売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2020～2031）
第4章薬物および遺伝子送達システムメーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2020～2025）
第5章：薬物および遺伝子送達システムの各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2020～2031）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2020～2031）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2020～2031）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2020～2031）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2020～2031）
第12章：薬物および遺伝子送達システムの主要メーカーの概要を提供し、製品の説明と仕様、薬物および遺伝子送達システムの売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2020～2025）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：薬物および遺伝子送達システムの市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

Market Analysis and Insights: Global Drug and Gene Delivery System Market
The global Drug and Gene Delivery System market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Drug and Gene Delivery System is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Drug and Gene Delivery System is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Drug and Gene Delivery System is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of Drug and Gene Delivery System include Pfizer, Johnson & Johnson, Novartis, Roche, Merck & Co., Sanofi, GlaxoSmithKline, AbbVie and AstraZeneca, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Drug and Gene Delivery System is widely used in various fields, such as Diabetes, Central Nervous System, Infectious Disease and Oncology, etc. Diabetes provides greatest supports to the Drug and Gene Delivery System industry development. In 2023, global % revenue of Drug and Gene Delivery System went into Diabetes filed and the proportion will reach to % in 2030. 
Report Covers:
This report presents an overview of global market for Drug and Gene Delivery System market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Drug and Gene Delivery System, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Drug and Gene Delivery System, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Drug and Gene Delivery System revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Drug and Gene Delivery System market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Drug and Gene Delivery System revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
    Pfizer
    Johnson & Johnson
    Novartis
    Roche
    Merck & Co.
    Sanofi
    GlaxoSmithKline
    AbbVie
    AstraZeneca
    Bayer
    Bristol-MyersSquibb
    Celgene
    Amgen
    Biogen
    Gilead Sciences
    Illumina
    Regeneron Pharmaceuticals
    Vertex Pharmaceuticals
    Moderna
    CRISPR Therapeutics

Segment by Type
    Drug Delivery System
    Gene Delivery System

Segment by Application
    Diabetes
    Central Nervous System
    Infectious Disease
    Oncology
    Other

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Drug and Gene Delivery System in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug and Gene Delivery System companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug and Gene Delivery System revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Drug and Gene Delivery System Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Drug Delivery System
    Table 3. Key Players of Gene Delivery System
    Table 4. Global Drug and Gene Delivery System Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 5. Global Drug and Gene Delivery System Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Drug and Gene Delivery System Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Drug and Gene Delivery System Market Share by Region (2019-2024)
    Table 8. Global Drug and Gene Delivery System Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Drug and Gene Delivery System Market Share by Region (2025-2030)
    Table 10. Drug and Gene Delivery System Market Trends
    Table 11. Drug and Gene Delivery System Market Drivers
    Table 12. Drug and Gene Delivery System Market Challenges
    Table 13. Drug and Gene Delivery System Market Restraints
    Table 14. Global Drug and Gene Delivery System Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Drug and Gene Delivery System Revenue Share by Players (2019-2024)
    Table 16. Global Top Drug and Gene Delivery System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug and Gene Delivery System as of 2023)
    Table 17. Global Drug and Gene Delivery System Industry Ranking 2022 VS 2023 VS 2024
    Table 18. Global 5 Largest Players Market Share by Drug and Gene Delivery System Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Global Key Players of Drug and Gene Delivery System, Headquarters and Area Served
    Table 20. Global Key Players of Drug and Gene Delivery System, Product and Application
    Table 21. Global Key Players of Drug and Gene Delivery System, Product and Application
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Drug and Gene Delivery System Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Drug and Gene Delivery System Revenue Market Share by Type (2019-2024)
    Table 25. Global Drug and Gene Delivery System Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Drug and Gene Delivery System Revenue Market Share by Type (2025-2030)
    Table 27. Global Drug and Gene Delivery System Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Drug and Gene Delivery System Revenue Share by Application (2019-2024)
    Table 29. Global Drug and Gene Delivery System Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Drug and Gene Delivery System Revenue Share by Application (2025-2030)
    Table 31. North America Drug and Gene Delivery System Market Size by Type (2019-2024) & (US$ Million)
    Table 32. North America Drug and Gene Delivery System Market Size by Type (2025-2030) & (US$ Million)
    Table 33. North America Drug and Gene Delivery System Market Size by Application (2019-2024) & (US$ Million)
    Table 34. North America Drug and Gene Delivery System Market Size by Application (2025-2030) & (US$ Million)
    Table 35. North America Drug and Gene Delivery System Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. North America Drug and Gene Delivery System Market Size by Country (2019-2024) & (US$ Million)
    Table 37. North America Drug and Gene Delivery System Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Europe Drug and Gene Delivery System Market Size by Type (2019-2024) & (US$ Million)
    Table 39. Europe Drug and Gene Delivery System Market Size by Type (2025-2030) & (US$ Million)
    Table 40. Europe Drug and Gene Delivery System Market Size by Application (2019-2024) & (US$ Million)
    Table 41. Europe Drug and Gene Delivery System Market Size by Application (2025-2030) & (US$ Million)
    Table 42. Europe Drug and Gene Delivery System Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Europe Drug and Gene Delivery System Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Europe Drug and Gene Delivery System Market Size by Country (2025-2030) & (US$ Million)
    Table 45. China Drug and Gene Delivery System Market Size by Type (2019-2024) & (US$ Million)
    Table 46. China Drug and Gene Delivery System Market Size by Type (2025-2030) & (US$ Million)
    Table 47. China Drug and Gene Delivery System Market Size by Application (2019-2024) & (US$ Million)
    Table 48. China Drug and Gene Delivery System Market Size by Application (2025-2030) & (US$ Million)
    Table 49. Asia Drug and Gene Delivery System Market Size by Type (2019-2024) & (US$ Million)
    Table 50. Asia Drug and Gene Delivery System Market Size by Type (2025-2030) & (US$ Million)
    Table 51. Asia Drug and Gene Delivery System Market Size by Application (2019-2024) & (US$ Million)
    Table 52. Asia Drug and Gene Delivery System Market Size by Application (2025-2030) & (US$ Million)
    Table 53. Asia Drug and Gene Delivery System Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 54. Asia Drug and Gene Delivery System Market Size by Region (2019-2024) & (US$ Million)
    Table 55. Asia Drug and Gene Delivery System Market Size by Region (2025-2030) & (US$ Million)
    Table 56. Middle East, Africa, and Latin America Drug and Gene Delivery System Market Size by Type (2019-2024) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Drug and Gene Delivery System Market Size by Type (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Drug and Gene Delivery System Market Size by Application (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Drug and Gene Delivery System Market Size by Application (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Drug and Gene Delivery System Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 61. Middle East, Africa, and Latin America Drug and Gene Delivery System Market Size by Country (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Drug and Gene Delivery System Market Size by Country (2025-2030) & (US$ Million)
    Table 63. Pfizer Company Details
    Table 64. Pfizer Business Overview
    Table 65. Pfizer Drug and Gene Delivery System Product
    Table 66. Pfizer Revenue in Drug and Gene Delivery System Business (2019-2024) & (US$ Million)
    Table 67. Pfizer Recent Developments
    Table 68. Johnson & Johnson Company Details
    Table 69. Johnson & Johnson Business Overview
    Table 70. Johnson & Johnson Drug and Gene Delivery System Product
    Table 71. Johnson & Johnson Revenue in Drug and Gene Delivery System Business (2019-2024) & (US$ Million)
    Table 72. Johnson & Johnson Recent Developments
    Table 73. Novartis Company Details
    Table 74. Novartis Business Overview
    Table 75. Novartis Drug and Gene Delivery System Product
    Table 76. Novartis Revenue in Drug and Gene Delivery System Business (2019-2024) & (US$ Million)
    Table 77. Novartis Recent Developments
    Table 78. Roche Company Details
    Table 79. Roche Business Overview
    Table 80. Roche Drug and Gene Delivery System Product
    Table 81. Roche Revenue in Drug and Gene Delivery System Business (2019-2024) & (US$ Million)
    Table 82. Roche Recent Developments
    Table 83. Merck & Co. Company Details
    Table 84. Merck & Co. Business Overview
    Table 85. Merck & Co. Drug and Gene Delivery System Product
    Table 86. Merck & Co. Revenue in Drug and Gene Delivery System Business (2019-2024) & (US$ Million)
    Table 87. Merck & Co. Recent Developments
    Table 88. Sanofi Company Details
    Table 89. Sanofi Business Overview
    Table 90. Sanofi Drug and Gene Delivery System Product
    Table 91. Sanofi Revenue in Drug and Gene Delivery System Business (2019-2024) & (US$ Million)
    Table 92. Sanofi Recent Developments
    Table 93. GlaxoSmithKline Company Details
    Table 94. GlaxoSmithKline Business Overview
    Table 95. GlaxoSmithKline Drug and Gene Delivery System Product
    Table 96. GlaxoSmithKline Revenue in Drug and Gene Delivery System Business (2019-2024) & (US$ Million)
    Table 97. GlaxoSmithKline Recent Developments
    Table 98. AbbVie Company Details
    Table 99. AbbVie Business Overview
    Table 100. AbbVie Drug and Gene Delivery System Product
    Table 101. AbbVie Revenue in Drug and Gene Delivery System Business (2019-2024) & (US$ Million)
    Table 102. AbbVie Recent Developments
    Table 103. AstraZeneca Company Details
    Table 104. AstraZeneca Business Overview
    Table 105. AstraZeneca Drug and Gene Delivery System Product
    Table 106. AstraZeneca Revenue in Drug and Gene Delivery System Business (2019-2024) & (US$ Million)
    Table 107. AstraZeneca Recent Developments
    Table 108. Bayer Company Details
    Table 109. Bayer Business Overview
    Table 110. Bayer Drug and Gene Delivery System Product
    Table 111. Bayer Revenue in Drug and Gene Delivery System Business (2019-2024) & (US$ Million)
    Table 112. Bayer Recent Developments
    Table 113. Bristol-MyersSquibb Company Details
    Table 114. Bristol-MyersSquibb Business Overview
    Table 115. Bristol-MyersSquibb Drug and Gene Delivery System Product
    Table 116. Bristol-MyersSquibb Revenue in Drug and Gene Delivery System Business (2019-2024) & (US$ Million)
    Table 117. Bristol-MyersSquibb Recent Developments
    Table 118. Celgene Company Details
    Table 119. Celgene Business Overview
    Table 120. Celgene Drug and Gene Delivery System Product
    Table 121. Celgene Revenue in Drug and Gene Delivery System Business (2019-2024) & (US$ Million)
    Table 122. Celgene Recent Developments
    Table 123. Amgen Company Details
    Table 124. Amgen Business Overview
    Table 125. Amgen Drug and Gene Delivery System Product
    Table 126. Amgen Revenue in Drug and Gene Delivery System Business (2019-2024) & (US$ Million)
    Table 127. Amgen Recent Developments
    Table 128. Biogen Company Details
    Table 129. Biogen Business Overview
    Table 130. Biogen Drug and Gene Delivery System Product
    Table 131. Biogen Revenue in Drug and Gene Delivery System Business (2019-2024) & (US$ Million)
    Table 132. Biogen Recent Developments
    Table 133. Gilead Sciences Company Details
    Table 134. Gilead Sciences Business Overview
    Table 135. Gilead Sciences Drug and Gene Delivery System Product
    Table 136. Gilead Sciences Revenue in Drug and Gene Delivery System Business (2019-2024) & (US$ Million)
    Table 137. Gilead Sciences Recent Developments
    Table 138. Illumina Company Details
    Table 139. Illumina Business Overview
    Table 140. Illumina Drug and Gene Delivery System Product
    Table 141. Illumina Revenue in Drug and Gene Delivery System Business (2019-2024) & (US$ Million)
    Table 142. Illumina Recent Developments
    Table 143. Regeneron Pharmaceuticals Company Details
    Table 144. Regeneron Pharmaceuticals Business Overview
    Table 145. Regeneron Pharmaceuticals Drug and Gene Delivery System Product
    Table 146. Regeneron Pharmaceuticals Revenue in Drug and Gene Delivery System Business (2019-2024) & (US$ Million)
    Table 147. Regeneron Pharmaceuticals Recent Developments
    Table 148. Vertex Pharmaceuticals Company Details
    Table 149. Vertex Pharmaceuticals Business Overview
    Table 150. Vertex Pharmaceuticals Drug and Gene Delivery System Product
    Table 151. Vertex Pharmaceuticals Revenue in Drug and Gene Delivery System Business (2019-2024) & (US$ Million)
    Table 152. Vertex Pharmaceuticals Recent Developments
    Table 153. Moderna Company Details
    Table 154. Moderna Business Overview
    Table 155. Moderna Drug and Gene Delivery System Product
    Table 156. Moderna Revenue in Drug and Gene Delivery System Business (2019-2024) & (US$ Million)
    Table 157. Moderna Recent Developments
    Table 158. CRISPR Therapeutics Company Details
    Table 159. CRISPR Therapeutics Business Overview
    Table 160. CRISPR Therapeutics Drug and Gene Delivery System Product
    Table 161. CRISPR Therapeutics Revenue in Drug and Gene Delivery System Business (2019-2024) & (US$ Million)
    Table 162. CRISPR Therapeutics Recent Developments
    Table 163. Research Programs/Design for This Report
    Table 164. Key Data Information from Secondary Sources
    Table 165. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Drug and Gene Delivery System Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Drug and Gene Delivery System Market Share by Type: 2023 VS 2030
    Figure 3. Drug Delivery System Features
    Figure 4. Gene Delivery System Features
    Figure 5. Global Drug and Gene Delivery System Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 6. Global Drug and Gene Delivery System Market Share by Application: 2023 VS 2030
    Figure 7. Diabetes Case Studies
    Figure 8. Central Nervous System Case Studies
    Figure 9. Infectious Disease Case Studies
    Figure 10. Oncology Case Studies
    Figure 11. Other Case Studies
    Figure 12. Drug and Gene Delivery System Report Years Considered
    Figure 13. Global Drug and Gene Delivery System Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Drug and Gene Delivery System Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Drug and Gene Delivery System Market Share by Region: 2023 VS 2030
    Figure 16. Global Drug and Gene Delivery System Market Share by Players in 2023
    Figure 17. Global Top Drug and Gene Delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug and Gene Delivery System as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Drug and Gene Delivery System Revenue in 2023
    Figure 19. North America Drug and Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Drug and Gene Delivery System Market Share by Type (2019-2030)
    Figure 21. North America Drug and Gene Delivery System Market Share by Application (2019-2030)
    Figure 22. North America Drug and Gene Delivery System Market Share by Country (2019-2030)
    Figure 23. United States Drug and Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada Drug and Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Drug and Gene Delivery System Market Size YoY (2019-2030) & (US$ Million)
    Figure 26. Europe Drug and Gene Delivery System Market Share by Type (2019-2030)
    Figure 27. Europe Drug and Gene Delivery System Market Share by Application (2019-2030)
    Figure 28. Europe Drug and Gene Delivery System Market Share by Country (2019-2030)
    Figure 29. Germany Drug and Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. France Drug and Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. U.K. Drug and Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Italy Drug and Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Russia Drug and Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Nordic Countries Drug and Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. China Drug and Gene Delivery System Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. China Drug and Gene Delivery System Market Share by Type (2019-2030)
    Figure 37. China Drug and Gene Delivery System Market Share by Application (2019-2030)
    Figure 38. Asia Drug and Gene Delivery System Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. Asia Drug and Gene Delivery System Market Share by Type (2019-2030)
    Figure 40. Asia Drug and Gene Delivery System Market Share by Application (2019-2030)
    Figure 41. Asia Drug and Gene Delivery System Market Share by Region (2019-2030)
    Figure 42. Japan Drug and Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. South Korea Drug and Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. China Taiwan Drug and Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Drug and Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. India Drug and Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Australia Drug and Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Drug and Gene Delivery System Market Size YoY (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Drug and Gene Delivery System Market Share by Type (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Drug and Gene Delivery System Market Share by Application (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Drug and Gene Delivery System Market Share by Country (2019-2030)
    Figure 52. Brazil Drug and Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Mexico Drug and Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Turkey Drug and Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Saudi Arabia Drug and Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Israel Drug and Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. GCC Countries Drug and Gene Delivery System Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Pfizer Revenue Growth Rate in Drug and Gene Delivery System Business (2019-2024)
    Figure 59. Johnson & Johnson Revenue Growth Rate in Drug and Gene Delivery System Business (2019-2024)
    Figure 60. Novartis Revenue Growth Rate in Drug and Gene Delivery System Business (2019-2024)
    Figure 61. Roche Revenue Growth Rate in Drug and Gene Delivery System Business (2019-2024)
    Figure 62. Merck & Co. Revenue Growth Rate in Drug and Gene Delivery System Business (2019-2024)
    Figure 63. Sanofi Revenue Growth Rate in Drug and Gene Delivery System Business (2019-2024)
    Figure 64. GlaxoSmithKline Revenue Growth Rate in Drug and Gene Delivery System Business (2019-2024)
    Figure 65. AbbVie Revenue Growth Rate in Drug and Gene Delivery System Business (2019-2024)
    Figure 66. AstraZeneca Revenue Growth Rate in Drug and Gene Delivery System Business (2019-2024)
    Figure 67. Bayer Revenue Growth Rate in Drug and Gene Delivery System Business (2019-2024)
    Figure 68. Bristol-MyersSquibb Revenue Growth Rate in Drug and Gene Delivery System Business (2019-2024)
    Figure 69. Celgene Revenue Growth Rate in Drug and Gene Delivery System Business (2019-2024)
    Figure 70. Amgen Revenue Growth Rate in Drug and Gene Delivery System Business (2019-2024)
    Figure 71. Biogen Revenue Growth Rate in Drug and Gene Delivery System Business (2019-2024)
    Figure 72. Gilead Sciences Revenue Growth Rate in Drug and Gene Delivery System Business (2019-2024)
    Figure 73. Illumina Revenue Growth Rate in Drug and Gene Delivery System Business (2019-2024)
    Figure 74. Regeneron Pharmaceuticals Revenue Growth Rate in Drug and Gene Delivery System Business (2019-2024)
    Figure 75. Vertex Pharmaceuticals Revenue Growth Rate in Drug and Gene Delivery System Business (2019-2024)
    Figure 76. Moderna Revenue Growth Rate in Drug and Gene Delivery System Business (2019-2024)
    Figure 77. CRISPR Therapeutics Revenue Growth Rate in Drug and Gene Delivery System Business (2019-2024)
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed